Skip to main content
Metaflammation SFB

News categories: Honors & Funding

Collaborative Research Center "Metaflammation" extended

With the participation of scientists from ImmunoSensation, the Collaborative Research Centre "Metaflammation and Cellular Programming" is investigating the links between lifestyle and inflammatory processes. The German Research Foundation has now extended funding for the research centre.

The CRC 1454 ‘Metaflammation and Cellular Programming’ is already entering its second funding period. It deals with the connection between a Western lifestyle and chronic inflammatory diseases - for example, how an excessive calorie intake coupled with insufficient exercise favours the development of cardiovascular diseases, neurodegenerative diseases or metabolic syndrome.

Using a holistic approach, the researchers are investigating why lifestyle or environmental factors, such as obesity, smoking or insufficient exercise, influence the misprogramming of immune cells and thus cause ‘metaflammation’ - a chronic inflammation triggered by the immune system. The researchers are investigating how the interaction of cells in inflamed tissue takes place and how molecular signalling pathways contribute to the development of diseases during metaflammation.

The scientific network is part of the Transdisciplinary Research Area (TRA) ‘Life and Health’ and combines the expertise of scientists from the Faculty of Medicine, the Faculty of Mathematics and Natural Sciences and the Faculty of Agricultural, Nutritional and Engineering Sciences as well as the Cluster of Excellence ImmunoSensation2 and the University Hospital Bonn (UKB). Researchers from the German Centre for Neurodegenerative Diseases (DZNE) in Bonn, the Max Planck Institute for Metabolic Research in Cologne, the German Rheumatism Research Centre in Berlin and the Technical University of Braunschweig are also involved.

Please visit the CRC Metaflammation website for further information.

 

Contact

Prof. Dagmar Wachten

Institute of Innate Immunity

University Hospital Bonn

E-Mail: dwachten@uni-bonn.de

 

Related news

Prof. Dr. Kaan Boztug

News categories: Honors & Funding

Kaan Boztug awarded Novartis Prize

Prof. Dr. Kaan Boztug from the University Hospital Bonn (UKB) receives the Novartis Prize for Therapy-Relevant Immunological Research 2025. The expert in rare diseases of the immune system and blood formation conducted most of the research work that has now been honored in Vienna. His work was supported by an ERC Starting Grant (ImmunoCore, 2012-2018) and an ERC Consolidator Grant (iDysChart, 2019-2025), among others. The science prize, worth 10,000 € is divided into two parts this time and also goes to Prof. Dr. Evelyn Ullrich.
View entry
Niklas Klümper

News categories: Honors & Funding

Niklas Klümper Receives Johann-Georg-Zimmermann Prize

PD Dr. Niklas Klümper was honored with the prestigious Johann-Georg-Zimmermann Research Prize. The €10,000 award is presented annually to young cancer researchers for their current scientific contributions.
View entry
Speakers of ImmunoSensation

News categories: Honors & Funding

ImmunoSensation goes into the next round

The Bonn Cluster of Excellence ImmunoSensation will be funded for further seven years as part of the Excellence Strategy of the German federal and state governments. The aim of the new funding period, which begins on January 1, 2026, is to research immune diversity: the structural, functional and dynamic diversity of the immune system. Involved are the University of Bonn, the University Hospital Bonn (UKB) and the German Center for Neurodegenerative Diseases (DZNE). The funding amounts to around 50 million euros.
View entry

Back to the news overview